Google
Trusted Resources: News & Events
Latest announcements and gatherings
Expert Opinion Hydroxyurea Could Prevent Strokes for People With Sickle Cell Disease in Lieu of Transfusions During COVID-19 Blood Supply Shortage
The COVID-19 pandemic threatens to cause a blood supply shortage in the United States, and as a result, clinicians may be compelled to ration or conserve blood products. For people living with sickle cell disease (SCD), blood transfusions are often necessary to decrease the frequency of severe symptoms.
In a new Blood paper, Michael R. DeBaun, MD, MPH, of Vanderbilt University Medical Center, Vanderbilt-Meharry Sickle Cell Disease Center of Excellence, suggests that while monthly blood transfusions are the standard method of stroke prevention for children with SCD and at high risk of strokes, initiation of hydroxyurea therapy may be an effective alternative, if the monthly blood transfusions are interrupted.
+myBinderRelated Content
-
Coronavirus Disease 2019 (COVID-19): People Who Need Extra Precautions; Groups at Higher Risk for Severe Illness –...COVID-19 is a new disease and there is l...
-
Sickle Cell Disease Hotline | Cayenne Wellness Center and Sickle Cell Disease Education & AwarenessPatients living with Sickle Cell Disease...
-
COVID-19 Resources for Non-Profit Leaders and the Community | National Organization for Rare DisordersThe health and safety of those with rare...
-
You Should Get a COVID-19 Vaccine – Portuguesehttps://www.youtube.com/watch?v=t8UywR9x...
-
Coping With Anxiety & Fear From Quarantine Dr. Gayle Rogers – WebinarThe Sickle Cell Mental Health Initiative...
-
COVID-19 and Sickle Cell Disease and Access to Care WebinarThe 14th Annual Sickle Cell Disease Rese...
-
MARAC Advisory Statement Regarding SCD Patients during the time of “Reopening” the U.S. EconomyMay 14, 2020—On Thursday April 16, 202...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.